Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation
- PMID: 37394531
- DOI: 10.1007/s00431-023-05086-x
Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation
Abstract
To investigate the clinical characteristics of Kawasaki disease (KD) presenting with abdominal manifestation as the first manifestation. Our findings may help improve the cognition of KD with abdominal complications, and avoid misdiagnosis and missed diagnosis. A retrospective analysis was conducted of 1490 KD patients admitted to Shengjing Hospital between January 2019 and March 2022. Clinical characteristics, related factors, and prognosis of KD with abdominal manifestation as first manifestation were analyzed. Based on the presenting symptoms, patients were divided into gastrointestinal symptom group (n = 141), liver dysfunction group (n = 55), and control group (n = 1294). In the gastrointestinal group, diarrhea [100 cases (70.9%)], vomiting [55 cases (39.0%)], and abdominal pain [34 cases (24.1%)] were the most common symptoms at onset. 8 cases (5.7%) were complicated with pseudo-intestinal obstruction, 6 cases (4.3%) with ischemic colitis, 5 cases (3.5%) with pancreatitis, 2 cases (1.4%) with appendicitis, and 1 case (0.7%) with cholecystitis. Comparied to ordinary gastroenteritis caused by infection, gastroenteritis with KD has longer fever duration before treatment, higher WBC, PLT, CRP, AST levels and lower albumin levels. All patients in the liver dysfunction group had elevated transaminases, and 19 patients (34.5%) presented with jaundice. In the gastrointestinal group, the average hospital stay was 10.3 days, and the incidence of IVIG unresponsiveness and coronary artery lesion were 18.4% and 19.9%, respectively, which were significantly higher than that in the control group. In the liver dysfunction group, the average hospital stay (11.18 days), incidence of IVIG unresponsiveness (25.5%), and incidence of coronary artery lesion (29.1%) were significantly higher than that in the control group. On multivariate logistic regression analysis, gastrointestinal involvement, fever duration, ALT, PLT, and CRP were identified as risk factors for CAL, younger age, gastrointestinal involvement and fever duration were risk factors for IVIG unresponsiveness. Conclusion: KD with gastrointestinal involvement is associated with a higher risk of IVIG unresponsiveness and coronary artery lesion. KD should be considered in the differential diagnosis of children with acute fever, especially those with gastrointestinal involvement and liver dysfunction. What is Known: • Fever duration, PLT, and CRP were identified as risk factors for CAL. Timely diagnosis and application of IVIG treatment can avoid exploratory laparotomy for ileus, appendectomy for misdiagnosed appendicitis, colonoscopy for misdiagnosed inflammatory bowel disease, and reduce the complications of CAL and IVIG unresponsiveness. What is New: • Abdominal symptoms as the first manifestation can be an independent risk factor for CAL and IVIG unresponsiveness. KD should be considered in the differential diagnosis of children with acute fever, especially those with gastrointestinal symptoms or liver dysfunction. • Gastroenteritis in KD group had longer fever duration before treatment, accompanied with higher WBC, PLT, CRP, AST levels and lower albumin levels than those gastroenteritis caused by infection. Therefore, high attention should be paid to the possibility of KD when gastroenteritis accompanied by along fever duration, high WBC, PLT, CRP, AST level or lowalbumin level.
Keywords: Abdominal manifestation; Coronary artery lesion; Hepatic dysfuction; IVIG unresponsiveness; Kawasaki disease.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Analysis of the clinical characteristics of patients with Kawasaki disease complicated with cholestasis.BMC Pediatr. 2024 Nov 27;24(1):777. doi: 10.1186/s12887-024-05278-w. BMC Pediatr. 2024. PMID: 39604995 Free PMC article.
-
[Clinical analysis of 942 cases of Kawasaki disease].Zhonghua Er Ke Za Zhi. 2006 May;44(5):324-8. Zhonghua Er Ke Za Zhi. 2006. PMID: 16780705 Chinese.
-
[Changes of P-selectin and E-selectin in children with Kawasaki disease].Zhonghua Er Ke Za Zhi. 2004 Sep;42(9):688-92. Zhonghua Er Ke Za Zhi. 2004. PMID: 15482673 Chinese.
-
Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children With Kawasaki Disease.Indian Pediatr. 2023 Mar 15;60(3):207-211. Epub 2023 Jan 2. Indian Pediatr. 2023. PMID: 36604937 Review.
-
Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis.Front Pediatr. 2020 Nov 20;8:593435. doi: 10.3389/fped.2020.593435. eCollection 2020. Front Pediatr. 2020. PMID: 33330287 Free PMC article.
Cited by
-
A Case With Typical Clinical Manifestations of Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Temporally Associated With SARS-CoV-2 Infection.Cureus. 2024 Jan 27;16(1):e53069. doi: 10.7759/cureus.53069. eCollection 2024 Jan. Cureus. 2024. PMID: 38410332 Free PMC article.
-
Relationship between Kawasaki disease and abdominal pain.World J Clin Cases. 2024 Jun 16;12(17):2932-2934. doi: 10.12998/wjcc.v12.i17.2932. World J Clin Cases. 2024. PMID: 38898859 Free PMC article.
-
Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review.BMC Pediatr. 2025 Aug 20;25(1):632. doi: 10.1186/s12887-025-05957-2. BMC Pediatr. 2025. PMID: 40830770 Free PMC article. Review.
-
Unraveling the gut: the pivotal role of intestinal mechanisms in Kawasaki disease pathogenesis.Front Immunol. 2024 Nov 26;15:1496293. doi: 10.3389/fimmu.2024.1496293. eCollection 2024. Front Immunol. 2024. PMID: 39664384 Free PMC article. Review.
-
Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.Food Sci Nutr. 2024 Dec 15;13(1):e4647. doi: 10.1002/fsn3.4647. eCollection 2025 Jan. Food Sci Nutr. 2024. PMID: 39803242 Free PMC article. Review.
References
-
- Alexoudi L, Kanakis M, Kapsimali V, Vaiopoulos G (2011) Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management. Autoimmune Rev 10:544–547. https://doi.org/10.1016/j.autrev.2011.04.005 - DOI
-
- Velez-Tirado N, Ridaura-Sanz C, Venegas-Montoya E, Scheffler-Mendoza S, Camacho-Moreno R, Otero-Mendoza F, Medina-Vega FA, Garrido-García LM, Rivas-Larrauri F, Nakashimada MAY (2019) Acute Abdomen in Kawasaki Disease. Indian J Pediatr 86:1151–1152. https://doi.org/10.1007/s12098-019-03048-6 - DOI - PubMed
-
- Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, Ancora G, Malaigia L, Bodnar T, Di FG et al (2018) Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease? PLoS One 13:e0202658. https://doi.org/10.1371/journal.pone.0202658
-
- Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385. https://doi.org/10.1161/01.cir.94.6.1379 - DOI - PubMed
-
- Newburger JW, Fulton DR (2004) Kawasaki disease. Curr Opin Pediatr 16:508–514. https://doi.org/10.1097/01.mop.0000137796.23813.64 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous